This advancement has the potential to transform conventional "flat" clinical trial data into detailed quantum-resolved biological maps Tel Aviv, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Viewbix Inc.
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
Study Finds on MSN
Viral Protein Found In Cancer, Lupus, ALS Traced To Infection From Millions Of Years Ago
Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...
A team of researchers led by University of California, Riverside biomedical scientists has identified a small, previously overlooked small RNA molecule that plays a major role in controlling the ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Global litigation over SEPs is facing new strategies by implementers, mainly related to venue selection. There is an ...
Detailed price information for Cannabix Technologies Inc (BLO-CN) from The Globe and Mail including charting and trades.
Discover how a Provisional Patent Application protects your invention with the "patent pending" label and learn about its benefits, limitations, and filing process with the USPTO.
TORONTO, ON / ACCESS Newswire / December 18, 2025 / Route1 Inc. (TSXV:ROI) ("Route1" or the "Company"), a leading engineering and professional services firm specializing in the deployment and ...
WEST HOLLYWOOD, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave”) or (the “Company”) today announced that it has initiated the patent-application ...
VisionWave (VWAV) Holdings announced that it has initiated the patent-application process for a planned series of patents with the goal of covering key technologies underlying Argus. This step follows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback